Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Schizophrenia

  Free Subscription


Articles published in PLoS One

Retrieve available abstracts of 88 articles:
HTML format
Text format



Single Articles


    January 2018
  1. MONACO A, Monda A, Amoroso N, Bertolino A, et al
    A complex network approach reveals a pivotal substructure of genes linked to schizophrenia.
    PLoS One. 2018;13:e0190110.
    PubMed     Text format     Abstract available


  2. KOBAYASHI M, Jitoku D, Iwayama Y, Yamamoto N, et al
    Association studies of WD repeat domain 3 and chitobiosyldiphosphodolichol beta-mannosyltransferase genes with schizophrenia in a Japanese population.
    PLoS One. 2018;13:e0190991.
    PubMed     Text format     Abstract available


  3. YERABHAM ASK, Muller-Schiffmann A, Ziehm T, Stadler A, et al
    Biophysical insights from a single chain camelid antibody directed against the Disrupted-in-Schizophrenia 1 protein.
    PLoS One. 2018;13:e0191162.
    PubMed     Text format     Abstract available


  4. PALACIOS-CENA D, Martin-Tejedor EA, Elias-Elispuru A, Garate-Samaniego A, et al
    The impact of a short-term cohousing initiative among schizophrenia patients, high school students, and their social context: A qualitative case study.
    PLoS One. 2018;13:e0190895.
    PubMed     Text format     Abstract available


  5. GONCALVES VF, Giamberardino SN, Crowley JJ, Vawter MP, et al
    Examining the role of common and rare mitochondrial variants in schizophrenia.
    PLoS One. 2018;13:e0191153.
    PubMed     Text format     Abstract available


  6. GUO S, Huang CC, Zhao W, Yang AC, et al
    Combining multi-modality data for searching biomarkers in schizophrenia.
    PLoS One. 2018;13:e0191202.
    PubMed     Text format     Abstract available


  7. GONZALEZ DE ARTAZA M, Catalan A, Angosto V, Valverde C, et al
    Can an experimental white noise task assess psychosis vulnerability in adult healthy controls?
    PLoS One. 2018;13:e0192373.
    PubMed     Text format     Abstract available


  8. VAESSEN TSJ, de Jong L, Schafer AT, Damen T, et al
    The interaction between cannabis use and the Val158Met polymorphism of the COMT gene in psychosis: A transdiagnostic meta - analysis.
    PLoS One. 2018;13:e0192658.
    PubMed     Text format     Abstract available


  9. CHIU CC, Lu ML, Huang MC, Chen PY, et al
    Correction: Effects of Low Dose Metformin on Metabolic Traits in Clozapine-Treated Schizophrenia Patients: An Exploratory Twelve-Week Randomized, Double-Blind, Placebo-Controlled Study.
    PLoS One. 2018;13:e0193315.
    PubMed     Text format     Abstract available


  10. SCHOTTLE D, Schimmelmann BG, Ruppelt F, Bussopulos A, et al
    Effectiveness of integrated care including therapeutic assertive community treatment in severe schizophrenia-spectrum and bipolar I disorders: Four-year follow-up of the ACCESS II study.
    PLoS One. 2018;13:e0192929.
    PubMed     Text format     Abstract available


  11. MANLEY W, Moreau MP, Azaro M, Siecinski SK, et al
    Validation of a microRNA target site polymorphism in H3F3B that is potentially associated with a broad schizophrenia phenotype.
    PLoS One. 2018;13:e0194233.
    PubMed     Text format     Abstract available


  12. EGLIT GML, Palmer BW, Martin AS, Tu X, et al
    Loneliness in schizophrenia: Construct clarification, measurement, and clinical relevance.
    PLoS One. 2018;13:e0194021.
    PubMed     Text format     Abstract available


  13. SBISA A, van den Buuse M, Gogos A
    The effect of estrogenic compounds on psychosis-like behaviour in female rats.
    PLoS One. 2018;13:e0193853.
    PubMed     Text format     Abstract available


  14. SHIMADA T, Ohori M, Inagaki Y, Shimooka Y, et al
    A multicenter, randomized controlled trial of individualized occupational therapy for patients with schizophrenia in Japan.
    PLoS One. 2018;13:e0193869.
    PubMed     Text format     Abstract available


  15. FASMER EE, Fasmer OB, Berle JO, Oedegaard KJ, et al
    Graph theory applied to the analysis of motor activity in patients with schizophrenia and depression.
    PLoS One. 2018;13:e0194791.
    PubMed     Text format     Abstract available


  16. GARCIA S, Alberich S, Martinez-Cengotitabengoa M, Arango C, et al
    The complex association between the antioxidant defense system and clinical status in early psychosis.
    PLoS One. 2018;13:e0194685.
    PubMed     Text format     Abstract available


  17. EGLOFF L, Studerus E, Zimmermann R, Heitz U, et al
    Evaluating verbal learning and memory in patients with an at-risk mental state or first episode psychosis using structural equation modelling.
    PLoS One. 2018;13:e0196936.
    PubMed     Text format     Abstract available


  18. GISSELGARD J, Lebedev AV, Daehli Kurz K, Joa I, et al
    Structural and functional alterations in the brain during working memory in medication-naive patients at clinical high-risk for psychosis.
    PLoS One. 2018;13:e0196289.
    PubMed     Text format     Abstract available


  19. RASSOVSKY Y, Dunn W, Wynn JK, Wu AD, et al
    Single transcranial direct current stimulation in schizophrenia: Randomized, cross-over study of neurocognition, social cognition, ERPs, and side effects.
    PLoS One. 2018;13:e0197023.
    PubMed     Text format     Abstract available


  20. KANCHANATAWAN B, Tangwongchai S, Supasitthumrong T, Sriswasdi S, et al
    Episodic memory and delayed recall are significantly more impaired in younger patients with deficit schizophrenia than in elderly patients with amnestic mild cognitive impairment.
    PLoS One. 2018;13:e0197004.
    PubMed     Text format     Abstract available


  21. KAGEYAMA M, Solomon P
    Post-traumatic stress disorder in parents of patients with schizophrenia following familial violence.
    PLoS One. 2018;13:e0198164.
    PubMed     Text format     Abstract available


  22. TORDESILLAS-GUTIERREZ D, Ayesa-Arriola R, Delgado-Alvarado M, Robinson JL, et al
    The right occipital lobe and poor insight in first-episode psychosis.
    PLoS One. 2018;13:e0197715.
    PubMed     Text format     Abstract available


  23. ZHANG T, Li J, Yu H, Shi Y, et al
    Meta-analysis of GABRB2 polymorphisms and the risk of schizophrenia combined with GWAS data of the Han Chinese population and psychiatric genomics consortium.
    PLoS One. 2018;13:e0198690.
    PubMed     Text format     Abstract available


  24. STEPIEN M, Manoliu A, Kubli R, Schneider K, et al
    Investigating the association of ventral and dorsal striatal dysfunction during reward anticipation with negative symptoms in patients with schizophrenia and healthy individuals.
    PLoS One. 2018;13:e0198215.
    PubMed     Text format     Abstract available


  25. KAWAKUBO Y, Yanagi M, Tsujii N, Shirakawa O, et al
    Repetition of verbal fluency task attenuates the hemodynamic activation in the left prefrontal cortex: Enhancing the clinical usefulness of near-infrared spectroscopy.
    PLoS One. 2018;13:e0193994.
    PubMed     Text format     Abstract available


  26. GUPTA P, Uner OE, Nayak S, Grant GR, et al
    SAP97 regulates behavior and expression of schizophrenia risk enriched gene sets in mouse hippocampus.
    PLoS One. 2018;13:e0200477.
    PubMed     Text format     Abstract available


  27. DAVIS KAS, Bashford O, Jewell A, Shetty H, et al
    Using data linkage to electronic patient records to assess the validity of selected mental health diagnoses in English Hospital Episode Statistics (HES).
    PLoS One. 2018;13:e0195002.
    PubMed     Text format     Abstract available


  28. TAJIRI M, Suzuki Y, Sugai T, Tsuneyama N, et al
    Effects of olanzapine on resting heart rate in Japanese patients with schizophrenia.
    PLoS One. 2018;13:e0199922.
    PubMed     Text format     Abstract available


  29. FUJITO NT, Satta Y, Hane M, Matsui A, et al
    Positive selection on schizophrenia-associated ST8SIA2 gene in post-glacial Asia.
    PLoS One. 2018;13:e0200278.
    PubMed     Text format     Abstract available


  30. BERRY S, Weinmann O, Fritz AK, Rust R, et al
    Loss of Nogo-A, encoded by the schizophrenia risk gene Rtn4, reduces mGlu3 expression and causes hyperexcitability in hippocampal CA3 circuits.
    PLoS One. 2018;13:e0200896.
    PubMed     Text format     Abstract available


  31. LEE LHN, Procyshyn RM, White RF, Woodward TS, et al
    Antipsychotic prescribing patterns on admission to and at discharge from a tertiary care program for treatment-resistant psychosis.
    PLoS One. 2018;13:e0199758.
    PubMed     Text format     Abstract available


  32. BERG AO, Jorgensen KN, Nerhus M, Athanasiu L, et al
    Vitamin D levels, brain volume, and genetic architecture in patients with psychosis.
    PLoS One. 2018;13:e0200250.
    PubMed     Text format     Abstract available


  33. HEIBERG IH, Jacobsen BK, Nesvag R, Bramness JG, et al
    Total and cause-specific standardized mortality ratios in patients with schizophrenia and/or substance use disorder.
    PLoS One. 2018;13:e0202028.
    PubMed     Text format     Abstract available


  34. BETTELLA F, Brown AA, Smeland OB, Wang Y, et al
    Cross-tissue eQTL enrichment of associations in schizophrenia.
    PLoS One. 2018;13:e0202812.
    PubMed     Text format     Abstract available


  35. JOO SW, Yoon W, Shon SH, Kim H, et al
    Altered white matter connectivity in patients with schizophrenia: An investigation using public neuroimaging data from SchizConnect.
    PLoS One. 2018;13:e0205369.
    PubMed     Text format     Abstract available


  36. SHIMADA T, Ohori M, Inagaki Y, Shimooka Y, et al
    Correction: A multicenter, randomized controlled trial of individualized occupational therapy for patients with schizophrenia in Japan.
    PLoS One. 2018;13:e0205549.
    PubMed     Text format     Abstract available


  37. RACIOPPI A, Sheinbaum T, Gross GM, Ballespi S, et al
    Prediction of prodromal symptoms and schizophrenia-spectrum personality disorder traits by positive and negative schizotypy: A 3-year prospective study.
    PLoS One. 2018;13:e0207150.
    PubMed     Text format     Abstract available


  38. OISHI K, Kanahara N, Takase M, Oda Y, et al
    Vulnerable combinations of functional dopaminergic polymorphisms to late-onset treatment resistant schizophrenia.
    PLoS One. 2018;13:e0207133.
    PubMed     Text format     Abstract available


    January 2017
  39. MOHITE S, Yang F, Amin PA, Zunta-Soares G, et al
    Plasma soluble L-selectin in medicated patients with schizophrenia and healthy controls.
    PLoS One. 2017;12:e0174073.
    PubMed     Text format     Abstract available


  40. WANG WC, Lu ML, Chen VC, Ng MH, et al
    Asthma, corticosteroid use and schizophrenia: A nationwide population-based study in Taiwan.
    PLoS One. 2017;12:e0173063.
    PubMed     Text format     Abstract available


  41. GUO W, Cai Y, Zhang H, Yang Y, et al
    Association of ARHGAP18 polymorphisms with schizophrenia in the Chinese-Han population.
    PLoS One. 2017;12:e0175209.
    PubMed     Text format     Abstract available


  42. RIVOLLIER F, Chaumette B, Bendjemaa N, Chayet M, et al
    Methylomic changes in individuals with psychosis, prenatally exposed to endocrine disrupting compounds: Lessons from diethylstilbestrol.
    PLoS One. 2017;12:e0174783.
    PubMed     Text format     Abstract available


  43. ARMANDO M, Schneider M, Pontillo M, Vicari S, et al
    No age effect in the prevalence and clinical significance of ultra-high risk symptoms and criteria for psychosis in 22q11 deletion syndrome: Confirmation of the genetically driven risk for psychosis?
    PLoS One. 2017;12:e0174797.
    PubMed     Text format     Abstract available


  44. SALVADOR R, Radua J, Canales-Rodriguez EJ, Solanes A, et al
    Evaluation of machine learning algorithms and structural features for optimal MRI-based diagnostic prediction in psychosis.
    PLoS One. 2017;12:e0175683.
    PubMed     Text format     Abstract available


  45. CALETTI E, Marotta G, Del Vecchio G, Paoli RA, et al
    The metabolic basis of cognitive insight in psychosis: A positron emission tomography study.
    PLoS One. 2017;12:e0175803.
    PubMed     Text format     Abstract available


  46. HOWELL KR, Floyd K, Law AJ
    PKBgamma/AKT3 loss-of-function causes learning and memory deficits and deregulation of AKT/mTORC2 signaling: Relevance for schizophrenia.
    PLoS One. 2017;12:e0175993.
    PubMed     Text format     Abstract available


  47. KIM GW, Kim YH, Jeong GW
    Whole brain volume changes and its correlation with clinical symptom severity in patients with schizophrenia: A DARTEL-based VBM study.
    PLoS One. 2017;12:e0177251.
    PubMed     Text format     Abstract available


  48. LIU H, Li L, Shen L, Wang X, et al
    Cavum septum pellucidum and first-episode psychosis: A meta-analysis.
    PLoS One. 2017;12:e0177715.
    PubMed     Text format     Abstract available


  49. RANDALL J, Chateau D, Bolton JM, Smith M, et al
    Increasing medication adherence and income assistance access for first-episode psychosis patients.
    PLoS One. 2017;12:e0179089.
    PubMed     Text format     Abstract available


  50. CONTRERAS F, Albacete A, Tebe C, Benejam B, et al
    Patients with schizophrenia activate behavioural intentions facilitated by counterfactual reasoning.
    PLoS One. 2017;12:e0178860.
    PubMed     Text format     Abstract available


  51. CHEN WY, Chen LY, Liu HC, Wu CS, et al
    Antipsychotic medications and stroke in schizophrenia: A case-crossover study.
    PLoS One. 2017;12:e0179424.
    PubMed     Text format     Abstract available


  52. YU Y, Liu ZW, Tang BW, Zhao M, et al
    Reported family burden of schizophrenia patients in rural China.
    PLoS One. 2017;12:e0179425.
    PubMed     Text format     Abstract available


  53. SQUARCINA L, Bellani M, Rossetti MG, Perlini C, et al
    Similar white matter changes in schizophrenia and bipolar disorder: A tract-based spatial statistics study.
    PLoS One. 2017;12:e0178089.
    PubMed     Text format     Abstract available


  54. BENOIT L, Moro MR, Falissard B, Henckes N, et al
    Psychosis risk research versus daily prognosis uncertainties: A qualitative study of French youth psychiatrists' attitudes toward predictive practices.
    PLoS One. 2017;12:e0179849.
    PubMed     Text format     Abstract available


  55. GIACOPUZZI E, Gennarelli M, Minelli A, Gardella R, et al
    Exome sequencing in schizophrenic patients with high levels of homozygosity identifies novel and extremely rare mutations in the GABA/glutamatergic pathways.
    PLoS One. 2017;12:e0182778.
    PubMed     Text format     Abstract available


  56. ATKINSON RJ, Fulham WR, Michie PT, Ward PB, et al
    Electrophysiological, cognitive and clinical profiles of at-risk mental state: The longitudinal Minds in Transition (MinT) study.
    PLoS One. 2017;12:e0171657.
    PubMed     Text format     Abstract available


  57. TOYOMAKI A, Hashimoto N, Kako Y, Murohashi H, et al
    Neural responses to feedback information produced by self-generated or other-generated decision-making and their impairment in schizophrenia.
    PLoS One. 2017;12:e0183792.
    PubMed     Text format     Abstract available


  58. PINHEIRO DS, Santos RDS, de Brito RB, Cruz AHDS, et al
    GSTM1/GSTT1 double-null genotype increases risk of treatment-resistant schizophrenia: A genetic association study in Brazilian patients.
    PLoS One. 2017;12:e0183812.
    PubMed     Text format     Abstract available


  59. POTKIN SG, Loze JY, Forray C, Baker RA, et al
    Relationship between response to aripiprazole once-monthly and paliperidone palmitate on work readiness and functioning in schizophrenia: A post-hoc analysis of the QUALIFY study.
    PLoS One. 2017;12:e0183475.
    PubMed     Text format     Abstract available


  60. PRIES LK, Guloksuz S, Menne-Lothmann C, Decoster J, et al
    White noise speech illusion and psychosis expression: An experimental investigation of psychosis liability.
    PLoS One. 2017;12:e0183695.
    PubMed     Text format     Abstract available


  61. SETIEN-SUERO E, Neergaard K, Ramirez-Bonilla M, Correa-Ghisays P, et al
    Cannabis use in male and female first episode of non-affective psychosis patients: Long-term clinical, neuropsychological and functional differences.
    PLoS One. 2017;12:e0183613.
    PubMed     Text format     Abstract available


  62. HAIMOVICH JS, Venkatesh AK, Shojaee A, Coppi A, et al
    Discovery of temporal and disease association patterns in condition-specific hospital utilization rates.
    PLoS One. 2017;12:e0172049.
    PubMed     Text format     Abstract available


  63. XU FL, Ding M, Yao J, Shi ZS, et al
    Association between mitochondrial DNA variations and schizophrenia in the northern Chinese Han population.
    PLoS One. 2017;12:e0182769.
    PubMed     Text format     Abstract available


  64. AFSHARI P, Yao WD, Middleton FA
    Reduced Slc1a1 expression is associated with neuroinflammation and impaired sensorimotor gating and cognitive performance in mice: Implications for schizophrenia.
    PLoS One. 2017;12:e0183854.
    PubMed     Text format     Abstract available


  65. ZAPRUTKO T, Kopciuch D, Kus K, Merks P, et al
    Affordability of medicines in the European Union.
    PLoS One. 2017;12:e0172753.
    PubMed     Text format     Abstract available


  66. PINSONNEAULT JK, Frater JT, Kompa B, Mascarenhas R, et al
    Intronic SNP in ESR1 encoding human estrogen receptor alpha is associated with brain ESR1 mRNA isoform expression and behavioral traits.
    PLoS One. 2017;12:e0179020.
    PubMed     Text format     Abstract available


  67. SULLIVAN S, Northstone K, Gadd C, Walker J, et al
    Models to predict relapse in psychosis: A systematic review.
    PLoS One. 2017;12:e0183998.
    PubMed     Text format     Abstract available


  68. DE CASTRO-CATALA M, Mora-Solano A, Kwapil TR, Cristobal-Narvaez P, et al
    The genome-wide associated candidate gene ZNF804A and psychosis-proneness: Evidence of sex-modulated association.
    PLoS One. 2017;12:e0185072.
    PubMed     Text format     Abstract available


  69. DECUYPERE F, Sermon J, Geerts P, Denee TR, et al
    Treatment continuation of four long-acting antipsychotic medications in the Netherlands and Belgium: A retrospective database study.
    PLoS One. 2017;12:e0179049.
    PubMed     Text format     Abstract available


  70. ERMAKOV EA, Smirnova LP, Bokhan NA, Semke AV, et al
    Catalase activity of IgG antibodies from the sera of healthy donors and patients with schizophrenia.
    PLoS One. 2017;12:e0183867.
    PubMed     Text format     Abstract available


  71. NAPOLITANO F, Booth Warren E, Migliarini S, Punzo D, et al
    Decreased Rhes mRNA levels in the brain of patients with Parkinson's disease and MPTP-treated macaques.
    PLoS One. 2017;12:e0181677.
    PubMed     Text format     Abstract available


  72. KANTOJARVI K, Liuhanen J, Saarenpaa-Heikkila O, Satomaa AL, et al
    Variants in calcium voltage-gated channel subunit Alpha1 C-gene (CACNA1C) are associated with sleep latency in infants.
    PLoS One. 2017;12:e0180652.
    PubMed     Text format     Abstract available


  73. WU Q, Luo X, Chen S, Qi C, et al
    Mental health literacy survey of non-mental health professionals in six general hospitals in Hunan Province of China.
    PLoS One. 2017;12:e0180327.
    PubMed     Text format     Abstract available


  74. DVEY-AHARON Z, Fogelson N, Peled A, Intrator N, et al
    Connectivity maps based analysis of EEG for the advanced diagnosis of schizophrenia attributes.
    PLoS One. 2017;12:e0185852.
    PubMed     Text format     Abstract available


  75. LEE H, Kim J
    Load-sensitive impairment of working memory for biological motion in schizophrenia.
    PLoS One. 2017;12:e0186498.
    PubMed     Text format     Abstract available


  76. JAKOBSEN AS, Speyer H, Norgaard HCB, Karlsen M, et al
    Effect of lifestyle coaching versus care coordination versus treatment as usual in people with severe mental illness and overweight: Two-years follow-up of the randomized CHANGE trial.
    PLoS One. 2017;12:e0185881.
    PubMed     Text format     Abstract available


  77. ABDIN E, Chong SA, Vaingankar JA, Peh CX, et al
    Trajectories of positive, negative and general psychopathology symptoms in first episode psychosis and their relationship with functioning over a 2-year follow-up period.
    PLoS One. 2017;12:e0187141.
    PubMed     Text format     Abstract available


  78. HUNG YY, Chan HY, Pan YJ
    Risk factors for readmission in schizophrenia patients following involuntary admission.
    PLoS One. 2017;12:e0186768.
    PubMed     Text format     Abstract available


  79. DEANE AR, Millar J, Bilkey DK, Ward RD, et al
    Maternal immune activation in rats produces temporal perception impairments in adult offspring analogous to those observed in schizophrenia.
    PLoS One. 2017;12:e0187719.
    PubMed     Text format     Abstract available


  80. MAGGIONI E, Crespo-Facorro B, Nenadic I, Benedetti F, et al
    Common and distinct structural features of schizophrenia and bipolar disorder: The European Network on Psychosis, Affective disorders and Cognitive Trajectory (ENPACT) study.
    PLoS One. 2017;12:e0188000.
    PubMed     Text format     Abstract available


  81. SHIMIZU N, Umemura T, Matsunaga M, Hirai T, et al
    An interactive sports video game as an intervention for rehabilitation of community-living patients with schizophrenia: A controlled, single-blind, crossover study.
    PLoS One. 2017;12:e0187480.
    PubMed     Text format     Abstract available



  82. Correction: Relationship between response to aripiprazole once-monthly and paliperidone palmitate on work readiness and functioning in schizophrenia: A post-hoc analysis of the QUALIFY study.
    PLoS One. 2017;12:e0188416.
    PubMed     Text format     Abstract available


  83. OLEJARCZYK E, Jernajczyk W
    Graph-based analysis of brain connectivity in schizophrenia.
    PLoS One. 2017;12:e0188629.
    PubMed     Text format     Abstract available


  84. MORERA-FUMERO AL, Diaz-Mesa E, Abreu-Gonzalez P, Fernandez-Lopez L, et al
    A three-month longitudinal study of changes in day/night serum total antioxidant capacity in paranoid schizophrenia.
    PLoS One. 2017;12:e0189348.
    PubMed     Text format     Abstract available


  85. ATTAR R, Berg Johansen M, Valentin JB, Aagaard J, et al
    Treatment following myocardial infarction in patients with schizophrenia.
    PLoS One. 2017;12:e0189289.
    PubMed     Text format     Abstract available


  86. BAKIRHAN A, Yalcin Sahiner S, Sahiner IV, Safak Y, et al
    Association of serum brain derived neurotropic factor with duration of drug-naive period and positive-negative symptom scores in drug naive schizophrenia.
    PLoS One. 2017;12:e0189373.
    PubMed     Text format     Abstract available


  87. CAMPBELL MM, Susser E, Mall S, Mqulwana SG, et al
    Using iterative learning to improve understanding during the informed consent process in a South African psychiatric genomics study.
    PLoS One. 2017;12:e0188466.
    PubMed     Text format     Abstract available


    January 2016
  88. SISKIND DJ, Leung J, Russell AW, Wysoczanski D, et al
    Metformin for Clozapine Associated Obesity: A Systematic Review and Meta-Analysis.
    PLoS One. 2016;11:e0156208.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Schizophrenia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: